[go: up one dir, main page]

DE1148989B - Process for the preparation of therapeutically useful calcium glucosamine citrates - Google Patents

Process for the preparation of therapeutically useful calcium glucosamine citrates

Info

Publication number
DE1148989B
DE1148989B DEB49251A DEB0049251A DE1148989B DE 1148989 B DE1148989 B DE 1148989B DE B49251 A DEB49251 A DE B49251A DE B0049251 A DEB0049251 A DE B0049251A DE 1148989 B DE1148989 B DE 1148989B
Authority
DE
Germany
Prior art keywords
glucosamine
calcium
citrates
preparation
therapeutically useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEB49251A
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joh A Benckiser GmbH
Original Assignee
Joh A Benckiser GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joh A Benckiser GmbH filed Critical Joh A Benckiser GmbH
Priority to DEB49251A priority Critical patent/DE1148989B/en
Publication of DE1148989B publication Critical patent/DE1148989B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Verfahren zur Herstellung von therapeutisch verwendbaren Calcium-Glucosamin-Citraten Es wurde gefunden, daß die therapeutische Wirkung von Calcium in Form von Calcium-Glucosamin-Citraten verbessert wird, und diese Calcium-Glucosamin-Citrate werden nach an sich bekannten Methoden hergestellt, indem man die Carboxylgruppen der Citronensäure ganz oder teilweise mit Calcium und Glucosamin ab sättigt. Process for the preparation of therapeutically useful calcium glucosamine citrates It has been found that the therapeutic effect of calcium is in the form of calcium glucosamine citrates is improved, and these calcium glucosamine citrates are known per se Methods prepared by removing all or the carboxyl groups of citric acid partially saturated with calcium and glucosamine.

Beispiel 1 Herstellung eines Calcium-Glucosamin-Citrates 21,0 g Citronensäure (mit 1 Mol Kristallwasser) werden in wenig Wasser gelöst, dann 10,0 g Calciumcarbonat in kleinen Portionen eingetragen und bis zur völligen Homogenität in einer Reibschale verrieben. Dann werden 17,9g Glucosamin mit 20 mol Wasser zugegeben, weiterhin gut durchgearbeitet und das Reaktionsprodukt im Vakuum über Phosphorpentoxyd getrocknet. Weißes kristallines Produkt. Example 1 Production of a Calcium Glucosamine Citrate 21.0 g of citric acid (with 1 mol of water of crystallization) are dissolved in a little water, then 10.0 g of calcium carbonate entered in small portions and in a mortar until completely homogeneous rubbed in. Then 17.9 g of glucosamine with 20 mol of water are added, still good worked through and the reaction product dried in vacuo over phosphorus pentoxide. White crystalline product.

Daß Calcium-Glucosamin-Citrate überraschende therapeutische Eigenschaften aufweisen, wobei die wesentlich verbesserte Resorption und Retention des Calciums hervorzuheben ist, geht aus den folgenden Versuchen hervor: Je fünfzehn Ratten mit einem Durchschnittsgewicht von 126 g wurden in drei Gruppen zu je fünf Tieren eingeteilt und erhielten Gruppen mit Ca4o markiertes Calciumcitrat (die Dosierung erfolgte so, daß 20mg Calcium gebunden als Calciumcitrat verabreicht wurden und die Aktivität des Ca45 20 C betrug); Gruppe II mit Ca45 markiertes Calcium-Glucosamin-Citrat (die Dosierung erfolgte so, daß 20mg Calcium und 11 mg Glucosamin in Form ihres gemeinsamen Citratsalzes verabreicht wurden und die Aktivität des Ca4; 20 t C betrug); Gruppe III mit Ca4 markiertes Calcium-Glucosamin-Citrat (die Dosierung erfolgte so, daß 20mg Calcium und 22 mg Glucosamin in Form ihres gemeinsamen Citratsalzes verabreicht wurden und die Aktivität 20 St C betrug). That Calcium Glucosamine Citrate has surprising therapeutic properties have, with the significantly improved absorption and retention of calcium is to be emphasized, emerges from the following experiments: Fifteen rats each with an average weight of 126 g were divided into three groups of five animals each and groups received calcium citrate labeled with Ca4o (dosing was carried out so that 20mg calcium bound as calcium citrate was administered and the activity des Ca45 was 20 C); Group II calcium glucosamine citrate labeled with Ca45 (the Dosage was done so that 20mg calcium and 11 mg glucosamine in the form of their common Citrate salt were administered and the activity of Ca4; 20 t C); group III calcium glucosamine citrate labeled with Ca4 (the dosage was carried out so that 20 mg calcium and 22 mg glucosamine are administered in the form of their common citrate salt and the activity was 20 St C).

Impulszahlen pro Minute Versuchsgruppe Knochen Zähne I 227 67,7 II 287 88,6 III 320 ; 83,7 Wie aus den Versuchsgruppen I bis III hervorgeht, wurden die Versuche unter streng vergleichbaren Bedingungen durchgeführt. Die Aktivität des Ca45 betrug in allen Gruppen 20 Mikro curie, und die verabreichten Calciummengen betrugen jeweils 20 Ca, wobei das Calcium als Calciumcitrat bzw. in Form von Calcium-Glucosamin-Citraten vorlag, wobei die verabreichten Calcium-Glucosamin-Citrate 11 bzw. 22 mg Glucosamin enthielten.Number of pulses per minute Test group bones teeth I 227 67.7 II 287 88.6 III 320; 83.7 As can be seen from test groups I to III, the tests were carried out under strictly comparable conditions. The activity of Ca45 was 20 microcurries in all groups, and the amounts of calcium administered were 20 Ca in each case, the calcium being in the form of calcium citrate or in the form of calcium-glucosamine-citrates, with the administered calcium-glucosamine-citrates 11 and 22, respectively mg of glucosamine.

Die in Knochen und Zähnen ermittelte Radioaktivität des in den Präparaten enthaltenen Ca45 wurde in üblicher Weise mit einem Zählrohr gemessen und in der Tabelle in Form der abgelesenen Impulszahlen pro Minute wiedergegeben. Diese Darstellung ist zulässig, da die radioaktive Markierung in allen Versuchsgruppen konstant war. The radioactivity found in the bones and teeth in the preparations Ca45 contained was measured in the usual way with a counter tube and in the Table reproduced in the form of the pulse numbers read per minute. This representation is permissible because the radioactive labeling was constant in all test groups.

Wie aus der vorstehenden Tabelle deutlich hervorgeht, haben die Calcium-Glucosamin-Citrate einen unerwartet starken positiven Einfluß auf die Resorption und Retention des Ca43, wenn dieses in den neuen Verbindungen vorliegt. Das Calcium wird aus diesen Verbindungen bevorzugt in Knochen und Zähnen eingebaut, so daß diese Präparate Kalk- mangelerscheinungen bei Mensch und Tier besonders gut beheben. As can be clearly seen from the table above, the calcium glucosamine citrates an unexpectedly strong positive influence on the absorption and retention of the Ca43 if this is present in the new compounds. The calcium is made from these Compounds preferably built into bones and teeth, so that these preparations lime deficiencies Resolve particularly well in humans and animals.

Versuchsanordnung Bei Experimenten zur Untersuchung des Einflusses der beiden Aminozucker auf den Kalkumsatz der Ratte hielt man sich an die von Schreier und Schnepf, Zschr. exper. Med., 127, 508 (1956), beschriebene Methodik. Insgesamt wurden fünfzehn Ratten (welche auf einer Standardität [Bahner] gehalten werden) für die hier mitgeteilten Untersuchungen verwendet. 18 Stunden nach Sondierung wurden die Ratten getötet und die Nagezähne, Femur, Tibia und Fibula der rechten, hinteren Extremität zur Bestimmung des radioaktiven Calciumgehaltes verarbeitet (Einzelheiten s. bei Schreier und Schnepf, S. 4). Die Aktivität eines jeden Präparates wurde aus dem Mittelwert - gewonnen durch vier bis fünf Messungen über jeweils 10 Minuten - errechnet. Experimental set-up For experiments to investigate the influence of the two amino sugars on the lime conversion of the rat one adhered to that of Schreier and Schnepf, Zschr. exper. Med., 127, 508 (1956). All in all fifteen rats (which are kept on a standard [Bahner]) used for the investigations reported here. 18 hours after probing were made the rats killed and the incisors, femur, tibia and fibula of the right, posterior one Extremity processed to determine the radioactive calcium content (details see Schreier and Schnepf, p. 4). The activity of each preparation was turned off to the Average value - obtained through four to five measurements over 10 minutes each - calculated.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von therapeutisch verwendbaren Calcium-Glucosamin-Citraten, dadurch gekennzeichnet, daß man die Carboxylgruppen der Citronensäure nach an sich bekannten Methoden mit Calcium und Glucosamin ganz oder teilweise absättigt. PATENT CLAIM: Process for the production of therapeutically usable Calcium glucosamine citrates, characterized in that the carboxyl groups the citric acid according to methods known per se with calcium and glucosamine whole or partially saturated. In Betracht gezogene Druckschriften: Deutsche Auslegeschriften Nr. 1022574, 1 024 948; Bechsteins Handbuch der organischen Chemie, 4. Auflage, 31. Band (1938), Seite 169/170; Chemical Abstracts, 35 (1941) Sp. 2477. Publications considered: German Auslegeschriften No. 1022574, 1,024,948; Bechstein's Handbook of Organic Chemistry, 4th edition, 31. Volume (1938), pp. 169/170; Chemical Abstracts, 35 (1941) Sp. 2477.
DEB49251A 1958-06-11 1958-06-11 Process for the preparation of therapeutically useful calcium glucosamine citrates Pending DE1148989B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEB49251A DE1148989B (en) 1958-06-11 1958-06-11 Process for the preparation of therapeutically useful calcium glucosamine citrates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB49251A DE1148989B (en) 1958-06-11 1958-06-11 Process for the preparation of therapeutically useful calcium glucosamine citrates

Publications (1)

Publication Number Publication Date
DE1148989B true DE1148989B (en) 1963-05-22

Family

ID=6968816

Family Applications (1)

Application Number Title Priority Date Filing Date
DEB49251A Pending DE1148989B (en) 1958-06-11 1958-06-11 Process for the preparation of therapeutically useful calcium glucosamine citrates

Country Status (1)

Country Link
DE (1) DE1148989B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1022574B (en) * 1956-01-20 1958-01-16 Ciba Geigy Process for the preparation of 1-amino-1-deoxy-2-ketoses and their salts

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1022574B (en) * 1956-01-20 1958-01-16 Ciba Geigy Process for the preparation of 1-amino-1-deoxy-2-ketoses and their salts
DE1024948B (en) * 1956-01-20 1958-02-27 Ciba Geigy Process for the preparation of 2-amino-2-deoxy-aldohexoses and their salts

Similar Documents

Publication Publication Date Title
DE1222213B (en) Spermicidal preparation
Benedict et al. The Solubility of Dental Enamel in Various Buffered Solutions1
DE2725246C2 (en)
DE1148989B (en) Process for the preparation of therapeutically useful calcium glucosamine citrates
DE951567C (en) Process for the preparation of antibiotic apparatus antothenates
DE951228C (en) Process for stabilizing an adrenocorticotropic preparation
AT398372B (en) Method for the prophylaxis of hypocalcaemic parturient paresis and of atypical milk fever in cattle
DE2025917C3 (en) Process for the preparation of N high alpha-acetyl-2-O-methyltyrosineoxytocins
Straumfjord Jr et al. In vivo synthesis of ascorbic acid by the alloxan diabetic rat
DD241071A5 (en) PROCESS FOR PREPARING A SALT OF DOBUTAMINE
DE2022653C (en) Growth-promoting combination of active ingredients for livestock
DE716089C (en) Process for the preparation of new derivatives of p-aminobenzenesulfonamide
Bauer et al. Rate of bone salt formation in a healing fracture determined in rats by means of radiophosphorus
DE2111557C3 (en) 1 - (3-SuIfamoyl-4-chloro-benzamido) -3- (2-furyl) -pyrrolidine and a process for its preparation
DE936592C (en) Process for the production of a blood and urine sugar lowering preparation from trioxyflavone glucoside-containing parts of plants
DE900872C (en) Process for the treatment of super polyamides
Fuller Influence of purified lignin on nitrification in soil
DE859513C (en) Process for the production of a therapeutic colloidal calcium phosphate preparation
DE821344C (en) Process for the production of water-soluble, absorbable calcium phosphates
DE1468554C (en) 20 beta tert amino 3 alpha hydroxy (or acyloxy) 5 beta pregnane or its salts and processes for their manufacture
DE839492C (en) Process for the production of highly swellable substances
DE619455C (en) Process for the production of adenosine phosphoric acid and adenosine polyphosphoric acid from animal organs
DE889896C (en) Process for the production of mono- or di-ethanol-amine hydrorhodanide
DE870410C (en) Process for the preparation of pregnane-3-ketones unsaturated in the core and in the side chain and their stereoisomers
DE820142C (en) Process for the preparation of a salt of heparic acid